<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Achondroplasia</z:e>, the most common form of <z:hpo ids='HP_0003510'>dwarfism</z:hpo> in man, is a dominant <z:e sem="disease" ids="C0019247" disease_type="Disease or Syndrome" abbrv="">genetic disorder</z:e> caused by a point mutation (G380R) in the transmembrane region of fibroblast growth factor receptor 3 (FGFR3) </plain></SENT>
<SENT sid="1" pm="."><plain>We used gene targeting to introduce the human <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">achondroplasia</z:e> mutation into the murine FGFR3 gene </plain></SENT>
<SENT sid="2" pm="."><plain>Heterozygotes for this point mutation that carried the neo cassette were <z:mpath ids='MPATH_458'>normal</z:mpath> whereas neo+ homozygotes had a phenotype similar to FGFR3-deficient mice, exhibiting bone <z:hpo ids='HP_0001548'>overgrowth</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>This was because of interference with <z:chebi fb="2" ids="33699">mRNA</z:chebi> processing in the presence of the neo cassette </plain></SENT>
<SENT sid="4" pm="."><plain>Removal of the neo selection marker by Cre/loxP recombination yielded a dominant dwarf phenotype </plain></SENT>
<SENT sid="5" pm="."><plain>These mice are distinguished by their small size, shortened craniofacial area, <z:mpath ids='MPATH_133'>hypoplasia</z:mpath> of the midface with protruding incisors, distorted brain case with anteriorly shifted foramen magnum, <z:hpo ids='HP_0002808'>kyphosis</z:hpo>, and narrowed and distorted growth plates in the long bones, vertebrae, and ribs </plain></SENT>
<SENT sid="6" pm="."><plain>These experiments demonstrate that <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">achondroplasia</z:e> results from a gain-of-FGFR3-function leading to inhibition of chondrocyte proliferation </plain></SENT>
<SENT sid="7" pm="."><plain>These <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">achondroplastic dwarf</z:e> mice represent a reliable and useful model for developing drugs for potential treatment of the human disease </plain></SENT>
</text></document>